Embelin-induced MCF-7 breast cancer cell apoptosis and blockade of MCF-7 cells in the G2/M phase via the mitochondrial pathway

Oncology Letters

Volumn 5, Issue 3, 2013, Pages 1005-1009

  Li, Yang ^a   Li, Dalei ^b   Yuan, Shengguang ^a   Wang, Zhenran ^a   Tang, Fang ^a   Nie, Rongrong ^a   Weng, Jun ^a   Ma, Lina ^b   Tang, Bo ^a  

^a GUILIN MEDICAL UNIVERSITY   (China)

^b Department of Neurology   (China)

Author keywords

Apoptosis; Breast cancer MCF 7 cell; Embelin; Mitochondria; XIAP

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; CYTOCHROME C; EMBELIN; PROTEIN BAX; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER INHIBITION; CELL VIABILITY; CONTROLLED STUDY; FLOW CYTOMETRY; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 84872705918     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2012.1084     Document Type: Article

References (25)

1. McPherson K, Steel CM and Dixon JM: ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics. BMJ 321: 624-628, 2000.
2. Benson JR and Jatoi I: The global breast cancer burden. Future Oncol 8: 697-702, 2012.
3. Anderson WF, Katki HA and Rosenberg PS: Incidence of breast cancer in the United States: current and future trends. J Natl Cancer Inst 103: 1397-1402, 2011.
4. Reuter S, Prasad S, Phromnoi K, Kannappan R, Yadav VR and AggarwalBB: Embelin suppresses osteoclastogenesis induced by receptor activator of NF-κB ligand and tumor cells invitro through inhibition of the NF-κB cell signaling pathway. Mol Cancer Res 8: 1425-1436, 2010.
5. Hu R, Zhu K, Li Y, Yao K, Zhang R, Wang H, Yang W and Liu Z: Embelin induces apoptosis through down-regulation of XIAP in human leukemia cells. Med Oncol 28: 1584-1588, 2011.
6. Nikolovska-Coleska Z, Xu L, Hu Z, Tomita Y, Li P, RollerPP, Wang R, Fang X, Guo R, Zhang M, Lippman ME, Yang D and Wang S: Discovery of embelin as a cell-permeable, small-molecular weight inhibitor of XIAP through structure-based computational screening of a traditional herbal medicine three-dimensional structure database. J Med Chem 47: 2430-2440, 2004.
7. Joshi R, Kamat JP and Mukherjee T: Free radical scavenging reactions and antioxidant activity of embelin: biochemical and pulse radiolytic studies. Chem Biol Interact 167: 125-134, 2007.
8. Sreepriya M and Bali G: Effects of administration of Embelin and Curcumin on lipid peroxidation, hepatic glutathione antioxidant defense and hematopoietic system during N-nitrosodiethylamine/Phenobarbital-induced hepatocarcinogenesis in Wistar rats. Mol Cell Biochem 284: 49-55, 2006.
9. Mahendran S, Badami S, Ravi S, Thippeswamy BS and VeerapurVP: Synthesis and evaluation of analgesic and anti-inflammatory activities of most active free radical scavenging derivatives of embelin-A structure-activity relationship. Chem Pharm Bull 59: 913-919, 2011.
10. Thippeswamy BS, Mahendran S, Biradar MI, Raj P, Srivastava K, Badami S and Veerapur VP: Protective effect of embelin against acetic acid induced ulcerative colitis in rats. Eur J Pharmacol 654: 100-105, 2011.
11. Danquah M, Li F, Duke CB III, Miller DD and MahatoRI: Micellar delivery of bicalutamide and embelin for treating prostate cancer. Pharm Res 26: 2081-2092, 2009.
12. Dai Y, Qiao L, Chan KW, Yang M, Ye J, Ma J, Zou B, Gu Q, Wang J, Pang R, Lan HY and Wong BC: Peroxisome proliferator-activated receptor-gamma contributes to the inhibitory effects of Embelin on colon carcinogenesis. Cancer Res 69: 4776-4783, 2009.
13. Aird KM, Ding X, Baras A, Wei J, Morse MA, Clay T, LyerlyHK and Devi GR: Trastuzumab signaling in ErbB2-overexpressing inflammatory breast cancer correlates with X-linked inhibitor of apoptosis protein expression. Mol Cancer Ther 7: 38-47, 2008.
14. Mori T, Doi R, Kida A, Nagai K, Kami K, Ito D, Toyoda E, Kawaguchi Y and Uemoto S: Effect of the XIAP inhibitor Embelin on TRAIL-induced apoptosis of pancreatic cancer cells. J Surg Res 142: 281-286, 2007.
15. Kerr JF, Wyllie AH and Currie AR: Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26: 239-257, 1972.
16. Chiarugi P and Giannoni E: Anoikis: a necessary death program for anchorage-dependent cells. Biochem Pharmacol 76: 1352-1364, 2008.
17. Allensworth JL, Aird KM, Aldrich AJ, Batinic-Haberle I and DeviGR: XIAP inhibition and generation of reactive oxygen species enhances TRAIL sensitivity in inflammatory breast cancer cells. Mol Cancer Ther 11: 1518-1527, 2012.
18. Tang B, Zhang Y, Liang R, Yuan P, Du J, Wang H and Wang L: Activation of the δ-opioid receptor inhibits serum deprivation-induced apoptosis of human liver cells via the activation of PKC and the mitochondrial pathway. Int J Mol Med 28: 1077-1085, 2011.
19. Mattson MP and Kroemer G: Mitochondria in cell death: novel targets for neuroprotection and cardioprotection. Trends Mol Med 9: 196-205, 2003.
20. Burlacu A: Regulation of apoptosis by Bcl-2 family proteins. JCell Mol Med 7: 249-257, 2003.
21. Saito M, Korsmeyer SJ and Schlesinger PH: BAX-dependent transport of cytochrome c reconstituted in pure liposomes. Nat Cell Biol 2: 553-555, 2000.
22. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, DingCK, Gallant M, Gareau Y, Griffin PR, Labelle M and LazebnikYA: Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376: 37-43, 1995.
23. Hyman BT and Yuan J: Apoptotic and non-apoptotic roles of caspases in neuronal physiology and pathophysiology. Nat Rev Neurosci 13: 395-406, 2012.
24. Riedl SJ and Shi Y: Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mol Cell Biol 5: 897-907, 2004.
25. Shi LG, Zhang GP and Jin HM: Inhibition of microvascular endothelial cell apoptosis by angiopoietin-1 and the involvement of cytochrome C. Chin Med J (Engl) 119: 725-730, 2006.